If you're looking for an under-the-radar stock that could deliver enormous gains in a defined time frame, the biopharmaceutical industry has you covered. Hardly a week goes by without clinical trial results or a regulatory decision that produces dramatic market movements.

U.S. stock indexes are rallying toward the close of their best week in two months. The S&P 500 rose 1.1% Friday.